RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Operating expenses

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 202447,197+13.56%
Dec 31, 202341,561+4.07%
Dec 31, 202239,937+4.35%
Dec 31, 202138,273+11.13%
Dec 31, 202034,441+69.80%
Dec 31, 201920,283-23.08%
Dec 31, 201826,370+41.59%
Dec 31, 201718,624+14.58%
Dec 31, 201616,254+6.08%
Dec 31, 201515,322-7.41%
Dec 31, 201416,549+26.08%
Dec 31, 201313,126

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)